Thank you, Madam Chair. I'll be splitting my time with Mr. Tilson.
I think it's important to be clear on what the exemption actually entails. There seems to be some misunderstanding here.
All the activities Ms. Evans and Ms. Hay raised—wound protection, needle exchange, psychological help, nursing care, all those things—will occur regardless of whether the exemption is extended or not. That's clearly something that Insite does, and I think everyone supports people getting treatment. And as you say, it's important to have treatment close to where these people reside. The issue of the exemption only deals with the illegal use of narcotics, and I think that is a very serious issue.
My question is to Mr. Mangham.
You mentioned the percentage of drug injections. I have the study here, and your memory served you well: it is less than 5% of all injections that occur at Insite. I wonder, if it's only 5%, whether that doesn't undermine a lot of the harm reduction. If 95% of injections are occurring outside of Insite, I assume a lot of harm is occurring away from Insite.